Article references (20 references )

  1. Speirs V, Shaaban AM et al. The rising incidence of male breast cancer. Breast Cancer Res Treat. 2008 may; 115(2): 429-30. PubMed | Google Scholar

  2. Yoney A, Kucuk A, Unsal M et al. Male breast cancer: a retrospectiveanalysis. Cancer/Radiothérapie. 2009 apr; 13(2): 103-107. PubMed | Google Scholar

  3. Sellal N, Haddad H, Bouchbika Z, Benchakroun N, Jouhadi H,Tawfiq N, Sahraoui S, Benider A. Cancer du sein: l'homme estaussi concerné: tude de 21 cas. Andrologie. 2011; 21(1): 45-51. é Google Scholar

  4. Bourhafour M, Belbaraka R, Souadka A, M'rabti H, Tijami F, Errihani H. Male breast cancer: a report of 127 cases at a Moroccan institution. BMC Research Notes. 2011 jun29; 4: 219. PubMed | Google Scholar

  5. Korde LA, Zujewski JA, Kamin L, Giordano S, Domchek S, Anderson WF et al. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010 apr; 28(12): 2114-2122. PubMed | Google Scholar

  6. Brinton LA, Key TJ, Kolonel LN et al. Prediagnostic sex steroid hormones in relation to male breast cancer risk. J Clin Oncol. 2015 jun; 33(18): 2041-50. PubMed | Google Scholar

  7. PDQ Adult Treatment Editorial Board. Male Breast Cancer Treatment (PDQ). Health professional Version. 2016 Feb 12. PubMed | Google Scholar

  8. Cutuli B, Cohen-Solal Le-Nir C, Serin D, Kirova Y, Gaci Z, Lemanski C, Male breast cancer et al. Evolution of treatment and prognostic factors: Analysis of 489 cases. Crit Rev Oncol Hematol. 2010 mar; 73(3): 246-254. PubMed | Google Scholar

  9. Renehan AG, Tyson M, Egger M et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008 Feb; 371(9612): 569-578. PubMed | Google Scholar

  10. Sonnenblick EB, Salvatore M, Szabo J, Lee KA, Margolies LR. Incremental role of mammography in the evaluation of gynecomastia in men who have undergone chest CT. AJR Am J Roentgenol. 2016 Aug; 207(2): 234-40. PubMed | Google Scholar

  11. NCCN (National Comprehensive Cancer Network) Breast Cancer Guidelines.

  12. Weiss JR, Moysich KB, Swede H. Epidemiology of male breastcancer. Cancer Epidemiol Biomarkers Prev. 2005 Jan; 14(1): 20-26. PubMed | Google Scholar

  13. Yu E, Stitt L, Vujovic O, Joseph K, Assouline A, Younus J et al. Male breast cancer prognostic factors versus female counterparts with propensity scores and matched-pair analysis. Cureus. 2015 Oct; 7(10): e355. PubMed | Google Scholar

  14. Evans DG, Bulman M, Young K, Howard E, Bayliss S, Wallace A et al. BRCA1/2 mutation analysis in male breast cancer families from North West England. Fam Cancer. 2008; 7(2): 113-117. PubMed | Google Scholar

  15. Zhu J, Davis CT, Silberman S, Spector N, Zhang T. A role for the androgen receptor in the treatment of male breast cancer. Crit Rev Oncol Hematol. 2016 Feb; 98: 358-363. PubMed | Google Scholar

  16. Farrow J, Adair F. Effect of orchiectomy on skeletal metastases from cancer of the male breast. Science. 1942 Jun; 95(2478): 654. PubMed | Google Scholar

  17. Volm Matthew D. Male breast cancer. Curr Treat Optios Oncol. 2003 Apr; 4(2): 159-164. PubMed | Google Scholar

  18. Laabadi K et al. Cancer du sein de l'homme: à propos de 6 cas. Pan Afr Med J. 2013 Oct; 16: 70. PubMed | Google Scholar

  19. Abreu MH et al. Male breast cancer: Looking for better prognostic subgroups. The Breast. 2015; 26: 18-24. PubMed | Google Scholar

  20. Masci G et al. Clinicopathological and immunohistochemical characteristics in male breast cancer: a retrospective case series. Oncologist. 2015 Jun; 20(6): 586-592. PubMed | Google Scholar